Investors who value dividend durability above all else — anyone who believes a 25+ year streak of increases is the strongest possible signal of corporate quality. Conservative equity investors seeking downside resilience without leaving equities entirely. Portfolio builders who want an equal-weighted approach that prevents concentration in mega-cap names and gives smaller aristocrats meaningful influence on performance.
Investors chasing maximum current yield — JEPI pays more than three times as much today. Growth-oriented investors who see a fund excluding entire sectors (no real estate, limited tech) and think it's too conservative. Anyone uncomfortable with equal-weighting, which means smaller aristocrats punch above their market-cap weight and can drag performance when large-caps rally.
NOBL's 25-year streak requirement inherently excludes younger high-growth companies that haven't yet had the time to build a quarter-century track record. This means NOBL can lag in growth-driven bull markets — 2020, 2023, and 2024 were all years where tech-led rallies left dividend aristocrats behind. The fund's equal-weighting methodology amplifies this: when large-cap growth stocks surge, the smaller aristocrats in NOBL's portfolio don't participate proportionally. Conversely, in value or defensive markets, NOBL's quality tilt and dividend durability screen provide meaningful outperformance relative to the broader market.
Key metrics
Fund snapshot
| Ticker | NOBL |
| Underlying Index | S&P 500 Dividend Aristocrats Index |
| Expense Ratio | 0.35% |
| AUM (approx.) | ~$11.3 billion |
| Inception Date | October 9, 2013 |
| Distribution Frequency | Quarterly (Mar, Jun, Sep, Dec) |
| Sponsor | ProShares |
| Number of Holdings | ~67 |
| 30-Day SEC Yield | ~2.1% (verify current) |
| Avg Daily Volume | ~725K shares |
Verify current data at Yahoo Finance. Yields and AUM change.
Performance snapshot
| Period | NOBL Return | Dividend Category Avg | S&P 500 (VOO) |
|---|---|---|---|
| 1 Year | ~5–9% | ~4–6% | underperforms |
| 3 Year (ann.) | ~4–7% | ~3–5% | underperforms |
| 5 Year (ann.) | ~10–13% | ~7–9% | underperforms |
| 10 Year (ann.) | ~9–12% | ~6–8% | underperforms |
Returns shown as approximate ranges. Verify exact figures at Yahoo Finance. Past performance is not indicative of future results. NOBL's 10-year annualized range reflects its full history since inception in October 2013.
NOBL's performance profile tells a clear story: it consistently underperforms the S&P 500 across all time periods, but it also tends to decline less during market downturns. The 25-year dividend-increase screen excludes high-growth sectors — particularly technology and real estate — that drive bull markets. In return, NOBL's holdings have demonstrated remarkable durability through recessions, earning its place as the defensive anchor of the Earn slot.
What it is and why it matters
What it actually is
NOBL tracks the S&P 500 Dividend Aristocrats Index — an index of companies within the S&P 500 that have increased their dividends for at least 25 consecutive years. This is not a broad dividend screen; it is one of the strictest filters in mainstream ETF investing. Out of approximately 500 S&P 500 constituents, roughly 67 qualify — fewer than 15%. The remaining 85%+ are excluded regardless of their current dividend yield, growth rate, or financial health. If a company has ever cut or skipped a dividend payment in the last 25 years, it is permanently ineligible.
The result is a portfolio concentrated in sectors known for stability: consumer staples (Procter & Gamble, Coca-Cola, Walmart), industrials (Caterpillar, 3M, Emerson Electric), healthcare (Johnson & Johnson, Merck, Abbott Laboratories), energy (Chevron, ExxonMobil), and financials (JPMorgan, Bank of America). Technology has minimal representation — only companies like Texas Instruments and IBM have long enough dividend histories to qualify. Real estate is entirely absent because REITs are excluded from the S&P 500 Dividend Aristocrats Index by construction.
The equal-weighting methodology
This is the detail most articles about NOBL miss, and it has meaningful portfolio implications. The index is equal-weighted — every holding receives approximately the same dollar allocation in the fund. With ~67 stocks, each position starts at roughly 1.5% of the portfolio. By contrast, virtually all other dividend ETFs (SCHD, VYM, VIG) are market-cap-weighted, meaning the largest holdings dominate performance.
The equal-weighting approach means smaller aristocrats punch well above their market-cap weight. A company like West Pharmaceutical Services (~$20B market cap) receives roughly the same dollar allocation as Caterpillar (~$200B market cap). This has two consequences: first, it prevents mega-cap names from dominating returns, creating a more diversified portfolio than market-cap-weighted alternatives. Second, it means NOBL's performance is driven by the average aristocrat rather than the largest ones — when smaller dividend growers rally, NOBL benefits disproportionately; when they lag, the fund feels it more acutely.
The index rebalances quarterly, which is more frequent than most dividend ETFs (many rebalance annually). This ensures that equal weighting is maintained and that companies added or removed from the aristocrat list are incorporated promptly.
The key insight: longevity as a quality signal
The single most important thing to understand about NOBL is what its 25-year dividend-increase requirement actually measures. A company that has raised its dividend every year for a quarter century has survived multiple recessions, interest rate cycles, industry disruptions, and management changes — all while maintaining the discipline to return more capital to shareholders each year. This is not a one-time event; it requires sustained financial strength, consistent cash flow generation, and management commitment to shareholder returns across decades.
NOBL investors are buying a portfolio of companies that have proven their durability through the longest possible track record available in public markets. The ~2.1% yield is not the primary attraction — it's the byproduct of 25+ years of annual increases. An investor who bought NOBL at inception in 2013 and held through today has seen the portfolio's aggregate dividend growth compound meaningfully, even though the fund itself distributes dividends quarterly rather than reinvesting them internally.
The real tradeoff
NOBL's strict 25-year requirement inherently excludes younger high-growth companies that haven't yet had the time to build a quarter-century track record. This means NOBL can lag in growth-driven bull markets — 2020, 2023, and 2024 were all years where tech-led rallies left dividend aristocrats behind. The fund's equal-weighting methodology amplifies this effect: when large-cap growth stocks surge, the smaller aristocrats in NOBL's portfolio don't participate proportionally to their market caps because they receive equal dollar allocations regardless of size.
Conversely, in value or defensive markets — periods when investors rotate out of high-growth names and into companies with proven cash flows and shareholder-friendly management — NOBL tends to outperform the broader market. The 2022 drawdown is a prime example: while the S&P 500 fell roughly 18%, NOBL declined less, benefiting from its quality tilt and defensive sector concentration.
Cost analysis
Expense ratio in context
NOBL charges 0.35% annually — significantly higher than the dividend equity category average of roughly 0.06–0.10% for passive funds like SCHD, VYM, and VIG. On $10,000, that is $35 per year versus $6 for SCHD. On $100,000, NOBL costs $350 annually while SCHD costs $60 — a $290 annual difference.
The higher expense ratio reflects ProShares' active management of the equal-weighting methodology and quarterly rebalancing. While the underlying index is rules-based, maintaining equal weights requires regular buying and selling as prices diverge from their target allocations — a process that generates transaction costs embedded in the expense ratio. For investors who specifically want the equal-weighted aristocrat approach, 0.35% is the price of admission; there is no cheaper way to access this exact strategy.
How it compares to alternatives
| Fund | Expense Ratio | AUM (approx.) | Yield (approx.) | 5-Yr Return (approx.) |
|---|---|---|---|---|
| NOBL | 0.35% | ~$11.3B | ~2.1% | ~10–13% ann. |
| SCHD | 0.06% | ~$65B | ~3.5% | ~11–14% ann. |
| VIG | 0.06% | ~$125B | ~1.5–1.8% | ~12–16% ann. |
| VYM | 0.06% | ~$55B | ~2.8–3.2% | ~10–12% ann. |
| KNG | 0.15% | ~$4B | ~2.3% | ~9–12% ann. |
Verify current data with fund sponsors. Yields fluctuate. Returns shown as approximate multi-year ranges.
Long-term compounding impact
On a $50,000 investment over 25 years at 10% annual total return, NOBL's 0.35% expense ratio costs approximately $9,800 in foregone growth compared to a zero-cost benchmark. By contrast, SCHD at 0.06% costs roughly $1,700 — a difference of about $8,100 over the full period. This is real money, and it accrues invisibly every year. For investors who specifically want NOBL's equal-weighted aristocrat approach, the cost premium is unavoidable; for those open to market-cap-weighted alternatives, SCHD or VIG offer similar dividend exposure at a fraction of the cost.
Dividend analysis
The 25-year streak requirement
The minimum threshold for NOBL is 25 consecutive years of annual dividend increases. This is not a rolling average, not a five-year trend, and not a discretionary assessment — it is a hard rule: if a company has not raised its dividend every single year for at least 25 years, it cannot be included in the index. This requirement immediately excludes the vast majority of S&P 500 companies. As of today, roughly 67 stocks qualify out of approximately 500 constituents — fewer than 15%.
The universe is further restricted to S&P 500 companies only. This excludes many smaller companies that have also maintained long dividend streaks but are not large enough to be in the S&P 500. Companies like Dover Corporation, Abbott Laboratories, and Genuine Parts Company qualify on streak length alone — they would be included if they were S&P 500 members. This universe restriction makes NOBL's filter even stricter than it might otherwise appear.
The equal-weighting effect on dividends
Because the index is equal-weighted, each of the ~67 holdings receives roughly the same dollar allocation — approximately 1.5% per stock. This means the portfolio's aggregate yield is a simple average of all constituent yields, not weighted toward the highest-yielding names. The result is a fund yield (~2.1%) that sits between the lowest aristocrat yields and the highest, rather than being pulled up by a few high-yield outliers as would happen in a market-cap-weighted approach.
This has meaningful implications for income investors. In a market-cap-weighted dividend fund, the yield is dominated by the largest holdings — if the biggest names happen to have low yields (as they often do among aristocrats), the overall fund yield can be surprisingly modest. NOBL's equal weighting ensures that smaller aristocrats with higher yields contribute proportionally more to the portfolio yield than they would in a market-cap-weighted alternative, while large-caps like Caterpillar and Chevron don't dominate the yield calculation simply because of their size.
Distribution mechanics
NOBL distributes dividends quarterly in March, June, September, and December — the standard ETF distribution schedule. Dividends from underlying holdings are collected throughout each quarter and distributed as a single payment at the end of the quarter. The fund does not automatically reinvest distributions; investors who want DRIP must set that up through their brokerage.
Dividend sustainability
NOBL's dividend is arguably more sustainable than most dividend ETFs because every holding has demonstrated — over a minimum 25-year period — the ability to maintain and grow payouts through multiple economic cycles. These are not companies that increased dividends during a single bull market; they have done so across recessions, rate hikes, industry disruptions, and management transitions. The quarterly rebalancing ensures that any company that cuts or skips a dividend is promptly removed from the index, providing an ongoing quality check on portfolio sustainability.
vs. the competition
NOBL vs VIG — Streak length and weighting methodology
The most direct comparison within the dividend-growth family is between NOBL's 25-year streak requirement and VIG's 10-year requirement. Both screen for consecutive dividend increases, but the threshold difference is enormous: a company must have raised dividends every year for a quarter century to join NOBL versus just a decade for VIG. This means NOBL holds roughly 67 stocks while VIG holds ~340 — a five-fold difference in universe size.
The weighting methodology further differentiates them. NOBL is equal-weighted (~1.5% per holding), giving smaller aristocrats outsized influence on performance. VIG is market-cap-weighted, meaning its largest holdings — Microsoft, Apple, UnitedHealth — dominate returns. This makes VIG's performance much more sensitive to mega-cap tech movements and closer to the S&P 500 overall.
NOBL is the stricter fund in every dimension: longer streak requirement, smaller universe, equal-weighting that prevents concentration. But it also underperforms VIG across most time periods because its exclusion of younger high-growth companies and limited tech exposure reduces participation in growth-led rallies. The tradeoff is clear: NOBL offers higher dividend durability at the cost of total return.
NOBL vs SCHD — Streak longevity vs quality screen
These two funds represent fundamentally different definitions of "quality." NOBL uses a single criterion — 25+ consecutive years of dividend increases — as its sole measure of corporate strength. SCHD uses four metrics: cash-debt-to-total-debt ratio, return on equity, debt-equity ratio, and earnings yield, plus a minimum payout ratio requirement. Neither approach is inherently superior; they simply emphasize different aspects of financial health.
The practical differences are significant. NOBL's single-criterion approach produces a portfolio concentrated in sectors with long dividend histories (consumer staples, industrials, healthcare) and minimal tech exposure. SCHD's multi-metric screen allows more sector diversity — it includes technology companies like Apple and Microsoft that score well on the quality metrics even though they haven't maintained 25-year dividend streaks. SCHD also has a higher current yield (~3.5% vs ~2.1%) because its quality screen doesn't exclude companies with lower yields.
NOBL investors believe that decades of dividend increases are the single best signal of corporate quality — a company that has raised dividends through multiple recessions and rate cycles has proven something fundamental about its business model. SCHD investors believe that current financial metrics (low debt, high ROE, attractive earnings yield) are more predictive of future performance than past dividend history. Both views have merit; the choice depends on which quality signal you trust more.
NOBL vs KNG — Aristocrats vs Kings
KNG (Invesco S&P Dividend Aristocrats ETF) tracks essentially the same index as NOBL — the S&P 500 Dividend Aristocrats Index. The difference is in the threshold: KNG requires 50+ consecutive years of dividend increases, while NOBL requires only 25+. This makes KNG even stricter and produces a much smaller universe — roughly 30 stocks versus NOBL's ~67.
The practical implications are meaningful. KNG's holdings are exclusively blue-chip stalwarts: companies like Johnson & Johnson, Coca-Cola, Procter & Gamble, and ExxonMobil that have raised dividends for half a century or more. These are among the most financially durable public companies in existence. NOBL includes these same names plus an additional ~37 aristocrats with 25–49 year streaks — companies like Target, NextEra Energy, and West Pharmaceutical Services that have demonstrated strong dividend discipline but haven't yet reached the half-century mark.
KNG charges 0.15% versus NOBL's 0.35%, reflecting its simpler (market-cap-weighted) methodology compared to NOBL's equal-weighting approach. Both funds are excellent choices for dividend durability; the choice between them depends on whether you want the absolute strictest filter (KNG) or a slightly broader aristocrat universe with equal weighting (NOBL).
Risks
NOBL is an equity fund and will decline in market downturns like any stock portfolio. Its 25-year dividend-increase screen provides meaningful downside resilience, but it does not eliminate risk. The following are the primary risks specific to this fund:
Sector concentration risk
NOBL's strict dividend-streak requirement produces a portfolio heavily concentrated in consumer staples, industrials, healthcare, and energy — sectors known for long dividend histories. Technology has minimal representation because most tech companies either don't pay dividends or haven't maintained 25-year streaks. Real estate is entirely absent. This sector tilt means NOBL can significantly underperform during periods when excluded sectors (particularly technology) lead the market.
Equal-weighting concentration risk
While equal weighting prevents mega-cap dominance, it creates a different kind of concentration: the portfolio's performance is driven by the average aristocrat rather than the largest names. When smaller aristocrats underperform — as they did during the 2020–2024 tech rally — NOBL feels this more acutely than market-cap-weighted alternatives where large-caps provide a stabilizing anchor.
Interest rate sensitivity
Many aristocrat holdings are in sectors (utilities, consumer staples, real estate-adjacent companies) that can be sensitive to rising interest rates. When rates increase rapidly, these sectors tend to underperform as investors rotate into higher-yielding fixed-income alternatives. NOBL's defensive character can work against it in rising-rate environments.
Liquidity risk
With average daily volume around 725K shares, NOBL is liquid enough for most investors but less actively traded than category leaders like SCHD or VYM. For large institutional orders, this could result in slippage. Retail investors buying typical positions (under $10,000) will not encounter meaningful liquidity issues.
Expense ratio risk
At 0.35%, NOBL is significantly more expensive than passive dividend alternatives like SCHD (0.06%) or VIG (0.06%). Over a multi-decade holding period, this expense differential compounds into meaningful underperformance relative to cheaper alternatives — even if NOBL's underlying strategy delivers comparable total returns.
Five Fund Frame fit
NOBL fills the Earn slot with a dividend-durability approach that is fundamentally different from other Earn candidates. While SCHD emphasizes current yield plus quality metrics and VIG focuses on dividend growth rate, NOBL enforces the strictest possible filter — 25+ consecutive years of annual increases from S&P 500 companies only. Its equal-weighting methodology gives it a unique risk profile within the slot: no single stock dominates, sector concentration is managed through breadth rather than selection, and downside resilience comes from the proven durability of every holding. In the Five Fund Frame, NOBL provides the defensive equity anchor — income generation with quality characteristics that have survived multiple economic cycles.